| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
2014-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105007918-B |
| titleOfInvention |
stable aqueous liquid formulation |
| abstract |
The present invention provides an aqueous liquid preparation with high stability to light and heat, characterized in that it contains (3‑{2‑[4‑isopropyl‑2‑(4‑trifluoromethyl)phenyl‑5 -thiazolyl]ethyl}-5-methyl-1,2-benzisoxazol-6-yl) glycolic acid or a pharmaceutically acceptable salt thereof, and tyloxapol or octoxynol. |
| priorityDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |